. 2019 Jun 20;104(10):4347–4355. doi: 10.1210/jc.2019-00828

Table 1.

Baseline Characteristics

	Testosterone (n = 42)	Placebo (n = 46)	P Value
Clinical characteristics
Age, y	28 ± 7	27 ± 7	0.29
Weight, kg	49 ± 5	50 ± 6	0.43
BMI, kg/m²	18.3 ± 1.8	18.3 ± 1.5	0.89
Duration of AN, y	12 ± 8	11 ± 7	0.93
AN subtype: restricting/binge-purge, %	67/33	72/28	0.65
MDD, %	64	59	0.66
GAD, %	74	67	0.64
Psychiatric medication use, %	71	76	0.64
Current amenorrhea, %	19	24	0.61
Estrogen status^a: replete/deplete, %	76/24	70/30	0.47
Combination oral contraceptive pill use, %	17	28	0.21
Hormone measurements
Total testosterone, ng/dL	26 ± 15	24 ± 14	0.42
Free testosterone, ng/dL	0.4 ± 0.2	0.4 ± 0.2	0.85

Data are mean ± SD unless otherwise indicated.

^{^a}

Estrogen replete is defined as having menses or taking exogenous estrogen within the last 3 mo, whereas estrogen deplete is defined as having no menses or exogenous estrogen within the last 3 mo.